adaptam THERAPEUTICS Logo (EUIPO, 05/10/2024)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark adaptam THERAPEUTICS was filed as Figurative mark on 05/10/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application opposed".
Logodesign (Wiener Klassifikation)
#Moiré surfaces or backgrounds, marble, degrading surfaces, wooden-like surfaces, rainbow colours surfaces #Three circles juxtaposed #Red, pink, orange #Blue
| Trademark form | Figurative mark |
| File reference | 019025232 |
| Application date | May 10, 2024 |
| Publication date | June 19, 2024 |
Trademark owner
Paseo de Miramon, nº 170 - planta 3ª
20014 San Sebastián - Donostia (Gipuzkoa)
ES
20014 San Sebastián - Donostia (Gipuzkoa)
ES
Trademark representatives
Passeig de Gràcia, 103, 7ª Planta
08008 Barcelona
ES
Objection / Complaint
goods and services
5
Pharmaceuticals and pharmaceutical preparations for use in the treatment of oncological diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of bone and skeletal diseases; Pharmaceuticals, including immunotherapeutic, and pharmaceutical preparations for the treatment and prevention of oncological diseases and disorders, acting at least in part through their actions on tumor-associated macrophages
42
Scientific research and development services in the field of pharmaceuticals and medical treatments, with a focus on the modulation of tumor-associated macrophages and immunotherapy for cancer and skeletal disease; laboratory research services for pharmaceuticals and medical treatments, with a focus on the modulation of tumor-associated macrophages and immunotherapy for cancer and skeletal disease; design and development of pharmaceutical formulations employing tumor-associated macrophage modulation and immunotherapy; clinical trials; medical and scientific research information services
44
Medical treatment services; immunotherapy services; healthcare consultancy services and healthcare services specializing in the diagnosis, prevention, and treatment of cancer and skeletal diseases through immunotherapy and tumor-associated macrophage modulation
ID: 11019025232